Clinical evidence implicating gamma-delta T cells in EBV control following cord blood transplantation
Laure Farnault(Aix-Marseille Université), Daniel Olive(Centre National de la Recherche Scientifique), Hérvè Chambost(Hôpital de la Timone), Françoise Gondois‐Rey(Inserm), Julie Gertner-Dardenne(Centre National de la Recherche Scientifique), Ivan Hirsch(Inserm), Gérard Michel(Hôpital de la Timone)
Cited by 50
Related Papers
Cardiovascular Toxicity Related to Cancer Treatment: A Pragmatic Approach to the American and European Cardio‐Oncology Guidelines
|Journal of the American Heart Association|2020|298
ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition
|Blood|2021|157
Bromohydrin pyrophosphate enhances antibody-dependent cell-mediated cytotoxicity induced by therapeutic antibodies
|Blood|2009|140
Hematopoietic cell transplantation in severe combined immunodeficiency: The SCETIDE 2006-2014 European cohort
|Journal of Allergy and Clinical Immunology|2021|110